PMID- 30223042 OWN - NLM STAT- MEDLINE DCOM- 20181211 LR - 20181211 IS - 2210-3244 (Electronic) IS - 1672-0229 (Print) IS - 1672-0229 (Linking) VI - 16 IP - 4 DP - 2018 Aug TI - TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis. PG - 276-282 LID - S1672-0229(18)30306-1 [pii] LID - 10.1016/j.gpb.2018.06.003 [doi] AB - Tumor-specific neoantigens have attracted much attention since they can be used as biomarkers to predict therapeutic effects of immune checkpoint blockade therapy and as potential targets for cancer immunotherapy. In this study, we developed a comprehensive tumor-specific neoantigen database (TSNAdb v1.0), based on pan-cancer immunogenomic analyses of somatic mutation data and human leukocyte antigen (HLA) allele information for 16 tumor types with 7748 tumor samples from The Cancer Genome Atlas (TCGA) and The Cancer Immunome Atlas (TCIA). We predicted binding affinities between mutant/wild-type peptides and HLA class I molecules by NetMHCpan v2.8/v4.0, and presented detailed information of 3,707,562/1,146,961 potential neoantigens generated by somatic mutations of all tumor samples. Moreover, we employed recurrent mutations in combination with highly frequent HLA alleles to predict potential shared neoantigens across tumor patients, which would facilitate the discovery of putative targets for neoantigen-based cancer immunotherapy. TSNAdb is freely available at http://biopharm.zju.edu.cn/tsnadb. CI - Copyright (c) 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved. FAU - Wu, Jingcheng AU - Wu J AD - Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. FAU - Zhao, Wenyi AU - Zhao W AD - Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. FAU - Zhou, Binbin AU - Zhou B AD - College of Computer Science and Technology, Zhejiang University, Hangzhou 310013, China. FAU - Su, Zhixi AU - Su Z AD - MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai 200438, China. FAU - Gu, Xun AU - Gu X AD - Department of Genetics, Development and Cell Biology, Iowa State University, Ames, IA 50011, USA. FAU - Zhou, Zhan AU - Zhou Z AD - Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: zhanzhou@zju.edu.cn. FAU - Chen, Shuqing AU - Chen S AD - Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: chenshuqing@zju.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180915 PL - England TA - Genomics Proteomics Bioinformatics JT - Genomics, proteomics & bioinformatics JID - 101197608 RN - 0 (Antigens, Neoplasm) RN - 0 (Tumor Suppressor Protein p53) SB - IM MH - Antigens, Neoplasm/*metabolism MH - *Data Analysis MH - *Databases, Genetic MH - Humans MH - Immunotherapy MH - Mutation/genetics MH - Neoplasms/*genetics/*immunology MH - Tumor Suppressor Protein p53/genetics MH - Urinary Bladder Neoplasms/genetics PMC - PMC6203688 OTO - NOTNLM OT - Cancer immunotherapy OT - Database OT - Human leukocyte antigen OT - Neoantigen OT - Somatic mutation EDAT- 2018/09/18 06:00 MHDA- 2018/12/12 06:00 PMCR- 2018/09/15 CRDT- 2018/09/18 06:00 PHST- 2018/03/19 00:00 [received] PHST- 2018/05/18 00:00 [revised] PHST- 2018/06/25 00:00 [accepted] PHST- 2018/09/18 06:00 [pubmed] PHST- 2018/12/12 06:00 [medline] PHST- 2018/09/18 06:00 [entrez] PHST- 2018/09/15 00:00 [pmc-release] AID - S1672-0229(18)30306-1 [pii] AID - 10.1016/j.gpb.2018.06.003 [doi] PST - ppublish SO - Genomics Proteomics Bioinformatics. 2018 Aug;16(4):276-282. doi: 10.1016/j.gpb.2018.06.003. Epub 2018 Sep 15.